Skip to content
Menu

Rapid Micro Biosystems, Inc. RPID

Full chart Compare
Set alert

Price alert · RPID

All alert types
0.74 USD 0.00 (-0.31%)

Regular-session close

0.74 0.00 +0.48%

After hours · Nov 19, 4:00 PM ET

0.7353 Day range 0.7366
0.58 52-week range 4.94
YTD
-74.64%
1 year
-83.14%

Analyst view

Price target (mean) 8.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 2
  • 1 month ago 2
  • 2 months ago 2

Included in Essentials and up

Sign in to see Revenue and earnings forecast

Reported revenue and earnings per share by year, then what analysts expect next.

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

RPID analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.225-0.24 – -0.21-0.26+13.5%7.60M+19.9%2
Next quarter-0.21-0.21 – -0.21-0.31+32.3%6.70M+19.4%1
Current year-1.08-1.09 – -1.06-1.22+11.9%27.45M+21.9%2
Next year-0.895-0.91 – -0.88-1.08+16.7%32.80M+19.5%2

Upgrades and downgrades

The latest rating changes

RPID analyst upgrades and downgrades
DateFirmActionFromTo
Mar 7, 2023Morgan StanleyReiterated—Equal-Weight
Aug 16, 2022JP MorganDowngradeOverweightNeutral
May 11, 2022Morgan StanleyMaintained—Equal-Weight
Mar 7, 2022Morgan StanleyMaintained—Equal-Weight
Feb 15, 2022Morgan StanleyMaintained—Equal-Weight
Nov 15, 2021Morgan StanleyMaintained—Equal-Weight
Aug 9, 2021Cowen & Co.Initiated—Outperform
Aug 9, 2021Morgan StanleyInitiated—Equal-Weight
Aug 9, 2021StifelInitiated—Buy
Aug 9, 2021JP MorganInitiated—Overweight

Included in Plus and up

Sign in to see Analyst trend

Two years of the analyst rating mix and the average price target against the price.